Apellis Pharmaceuticals Stock Forecast - 4 Period Moving Average
| APLS Stock | USD 49.93 1.21 2.48% |
The 4 Period Moving Average forecasted value of Apellis Pharmaceuticals on the next trading day is expected to be 49.05 with a mean absolute deviation of 1.83 and the sum of the absolute errors of 106.42. Apellis Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Apellis Pharmaceuticals stock prices and determine the direction of Apellis Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Apellis Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Apellis Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Apellis Pharmaceuticals' systematic risk associated with finding meaningful patterns of Apellis Pharmaceuticals fundamentals over time.
Check out Historical Fundamental Analysis of Apellis Pharmaceuticals to cross-verify your projections. Apellis |
Open Interest Against 2024-05-17 Apellis Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Apellis Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Apellis Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Apellis Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Apellis Pharmaceuticals' open interest, investors have to compare it to Apellis Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Apellis Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Apellis. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Apellis Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Apellis Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Apellis Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
A four-period moving average forecast model for Apellis Pharmaceuticals is based on an artificially constructed daily price series in which the value for a given day is replaced by the mean of that value and the values for four preceding and succeeding time periods. This model is best suited to forecast equities with high volatility. Apellis Pharmaceuticals 4 Period Moving Average Price Forecast For the 26th of April
Given 90 days horizon, the 4 Period Moving Average forecasted value of Apellis Pharmaceuticals on the next trading day is expected to be 49.05 with a mean absolute deviation of 1.83, mean absolute percentage error of 5.32, and the sum of the absolute errors of 106.42.Please note that although there have been many attempts to predict Apellis Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Apellis Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Apellis Pharmaceuticals Stock Forecast Pattern
| Backtest Apellis Pharmaceuticals | Apellis Pharmaceuticals Price Prediction | Buy or Sell Advice |
Apellis Pharmaceuticals Forecasted Value
In the context of forecasting Apellis Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Apellis Pharmaceuticals' downside and upside margins for the forecasting period are 46.06 and 52.05, respectively. We have considered Apellis Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Apellis Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Apellis Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.2678 |
| Bias | Arithmetic mean of the errors | 0.6082 |
| MAD | Mean absolute deviation | 1.8347 |
| MAPE | Mean absolute percentage error | 0.0316 |
| SAE | Sum of the absolute errors | 106.415 |
Predictive Modules for Apellis Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Apellis Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Apellis Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Apellis Pharmaceuticals
For every potential investor in Apellis, whether a beginner or expert, Apellis Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Apellis Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Apellis. Basic forecasting techniques help filter out the noise by identifying Apellis Pharmaceuticals' price trends.Apellis Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Apellis Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Apellis Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Apellis Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Apellis Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Apellis Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Apellis Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Apellis Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Apellis Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Apellis Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Apellis Pharmaceuticals stock market strength indicators, traders can identify Apellis Pharmaceuticals entry and exit signals to maximize returns.
Apellis Pharmaceuticals Risk Indicators
The analysis of Apellis Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Apellis Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting apellis stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.2 | |||
| Standard Deviation | 2.94 | |||
| Variance | 8.61 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Apellis Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Apellis Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Apellis Stock
| 0.67 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.67 | XFOR | X4 Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.66 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.64 | ELYM | Eliem Therapeutics | PairCorr |
| 0.64 | NRSNW | NeuroSense Therapeutics | PairCorr |
The ability to find closely correlated positions to Apellis Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Apellis Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Apellis Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Apellis Pharmaceuticals to buy it.
The correlation of Apellis Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Apellis Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Apellis Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Apellis Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Apellis Pharmaceuticals to cross-verify your projections. For more information on how to buy Apellis Stock please use our How to Invest in Apellis Pharmaceuticals guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Apellis Stock analysis
When running Apellis Pharmaceuticals' price analysis, check to measure Apellis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apellis Pharmaceuticals is operating at the current time. Most of Apellis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apellis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apellis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apellis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Apellis Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apellis Pharmaceuticals. If investors know Apellis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apellis Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.45) | Revenue Per Share 3.342 | Quarterly Revenue Growth 5.459 | Return On Assets (0.42) | Return On Equity (2.90) |
The market value of Apellis Pharmaceuticals is measured differently than its book value, which is the value of Apellis that is recorded on the company's balance sheet. Investors also form their own opinion of Apellis Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Apellis Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apellis Pharmaceuticals' market value can be influenced by many factors that don't directly affect Apellis Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apellis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Apellis Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apellis Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.